Kezar Life Sciences Inc. (NASDAQ: KZR)
$0.69
+0.0440 ( +6.77% ) 432.7K
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Market Data
Open
$0.69
Previous close
$0.65
Volume
432.7K
Market cap
$50.54M
Day range
$0.65 - $0.70
52 week range
$0.54 - $2.55
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| ars | Annual reports | 1 | Apr 26, 2024 |
| def | Proxies and info statements | 17 | Apr 26, 2024 |
| pre | Proxies and info statements | 17 | Apr 16, 2024 |
| 10-k | Annual reports | 96 | Mar 14, 2024 |
| 8-k | 8K-related | 13 | Mar 14, 2024 |
| 3 | Insider transactions | 2 | Jan 17, 2024 |
| 4 | Insider transactions | 1 | Jan 09, 2024 |
| 4 | Insider transactions | 1 | Jan 09, 2024 |
| 8-k | 8K-related | 10 | Jan 08, 2024 |
| 8-k | 8K-related | 12 | Dec 04, 2023 |